Skip to main content

Products

Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.

Connect With Us

All Products (346)

Clear all filters
Clear all filters

Tisotumab Vedotin

Targeted Therapy (Antibody-Drug Conjugate)

Therapeutic Category

Targeted Therapy (Antibody-Drug Conjugate)

Oncology Type

Solid Tumour

Drug Class / Mechanism

ADC

Tivantinib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Solid Tumour

Drug Class / Mechanism

Multi-Kinase / Anti-Angiogenic Inhibitor

Tivozanib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Solid Tumour

Drug Class / Mechanism

Multi-Kinase / Anti-Angiogenic Inhibitor

Tovorafenib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Solid Tumour

Drug Class / Mechanism

BRAF / MEK Inhibitor

Trametinib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Solid Tumour

Drug Class / Mechanism

BRAF / MEK Inhibitor

Trastuzumab

Targeted Therapy (Antibody / ADC)

Therapeutic Category

Targeted Therapy (Antibody / ADC)

Oncology Type

Solid Tumour (Breast/Gastric)

Drug Class / Mechanism

Anti-HER2 Agent

Trastuzumab Duocarmazine

Targeted Therapy (Antibody / ADC)

Therapeutic Category

Targeted Therapy (Antibody / ADC)

Oncology Type

Solid Tumour (Breast/Gastric)

Drug Class / Mechanism

Anti-HER2 Agent

Triciribine

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Solid Tumour

Drug Class / Mechanism

AKT Inhibitor

Trilaciclib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Solid Tumour

Drug Class / Mechanism

CDK Inhibitor

Tucatinib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Solid Tumour

Drug Class / Mechanism

EGFR / HER2 Tyrosine Kinase Inhibitor

Tuvusertib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Solid Tumour

Drug Class / Mechanism

DNA Damage Response Inhibitor (WEE1/ATR/CHK1)

Ulixertinib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Solid Tumour

Drug Class / Mechanism

BRAF / MEK Inhibitor